CD8A and ovarian carcinoma: Indeed, a recent report has demonstrated that EVs from ovarian cancers transit over long distances to the draining lymph node where they deliver arginase-1 to DCs resulting in a suppression of CD4+ and CD8+ T cell proliferation (54).